COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,050 Articles (22,627 medRxiv, 8,423 bioRxiv)

Most recent first Previous |  Page 2673: Articles 26721-26730  | Next

High Resolution CHEST CT(HRCT) Evaluation in Patients Hospitalized with COVID-19 Infection
Patel, M., Chowdhury, J., Zheng, M., Abramian, O., Verga, S., Zhao, H., Patlakh, N., Fleece, D., Cohen, G., Kumaran, M., Dass, C., Criner, G.
10.1101/2020.05.26.20114082 — Posted: 2020-05-28
Mental health outcomes and associations during the coronavirus disease 2019 pandemic: A cross-sectional survey of the US general population
Kantor, B. N., Kantor, J.
10.1101/2020.05.26.20114140 — Posted: 2020-05-28
Factors associated with country-variation in COVID-19 morbidity and mortality worldwide: an observational geographic study
Bellali, H., Chtioui, N., Chahed, M.
10.1101/2020.05.27.20114280 — Posted: 2020-05-28
Automated and partially-automated contact tracing: a rapid systematic review to inform the control of COVID-19
Braithwaite, I., Callender, T., Bullock, M., Aldridge, R. W.
10.1101/2020.05.27.20114447 — Posted: 2020-05-28
Unspecific post-mortem findings despite multiorgan 1 viral spread in COVID-19 patients
Remmelink, M., De Mendoca, R., D'Haene, N., De Clercq, S., Verocq, C., Lebrun, L., Lavis, P., Racu, M. L., Trepant, A. L., Maris, C., Rorive, S., Goffard, J. C., De Witte, O., Peluso, L., Vincent, J. L., Decaestecker, C., Taccone, F. S., Salmon, I.
10.1101/2020.05.27.20114363 — Posted: 2020-05-28
Assessment of ACE2, CXCL10 and Their co-expressed Genes: An In-silico Approach to Evaluate the Susceptibility and Fatality of Lung Cancer Patients towards COVID-19 Infection
Mahmood, T. B., Chowdhury, A. S., Hasan, M., Aakil, M. M.-U.-I., Hossan, M. I.
10.1101/2020.05.27.119610 — Posted: 2020-05-27
SARS-CoV-2 envelope protein topology in eukaryotic membranes
Duart, G., Garcia-Murria, M. J., Grau, B., Acosta-Caceres, J. M., Martinez-Gil, L., Mingarro, I.
10.1101/2020.05.27.118752 — Posted: 2020-05-27
Enantiomers of Chloroquine and Hydroxychloroquine Exhibit Different Activities Against SARS-CoV-2 in vitro, Evidencing S-Hydroxychloroquine as a Potentially Superior Drug for COVID-19
Li, G., Sun, J., Li, Y., Shi, Y., Zhao, J., Zhang, T. Y., Zhang, X.
10.1101/2020.05.26.114033 — Posted: 2020-05-27 Discussion: Onsite | Offsite
Assessment of sample pooling for clinical SARS-CoV-2 testing
St. George, K., Griesemer, S. B., Van Slyke, G.
10.1101/2020.05.26.118133 — Posted: 2020-05-27
Impact of Comorbidities on the Expression of SARS-CoV-2 Viral Entry-Related Genes
Breidenbach, J. D., Dube, P., Ghosh, S., Modyanov, N. N., Malhotra, D., Dworkin, L. D., Haller, S. T., Kennedy, D. J.
10.1101/2020.05.26.117440 — Posted: 2020-05-27

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).